shiga toxin producing escherichia coli Infection, antibiotics, and risk of developing hemolytic uremic syndrome, a case control study

shiga toxin producing escherichia coli Infection, antibiotics, and risk of developing hemolytic uremic syndrome, a case control study - shiga toxin producing escherichia coli Infection, antibiotics, and risk of developing hemolytic uremic syndrome, a case control study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000037165

Enrollment

400

Registered

2019-06-28

Start date

2019-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hemolytic uremic syndrome

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Shiga toxin-producing Escherichia coli infection cases registered from January 1st 2017 to December 31th 2018 under the infection law.

Exclusion criteria

Exclusion criteria: 1. Asymptomatic patients. 2. Cases which researchers cannot reach the detailed information. 3. Cases whose form of questionnaires are not detailed.

Design outcomes

Primary

Measure	Time frame
Hemolytic uremic syndrome	—

Countries

Japan

Contacts

Public ContactIsao Miyairi

National Center for Child Health and Development Division of Infectious diseases

miyairi-s@ncchd.go.jp03-3416-0181

Outcome results